Literature DB >> 3492514

Idiotypic markers of polyclonal B cell activation. Public idiotypes shared by monoclonal antibodies derived from patients with systemic lupus erythematosus or leprosy.

C Mackworth-Young, J Sabbaga, R S Schwartz.   

Abstract

We investigated idiotypic markers of monoclonal antibodies derived from patients with polyclonal B-cell activation. Four monoclonal antibodies with different ligand binding specificities derived from a patient with lepromatous leprosy and three monoclonal anti-DNA antibodies from two patients with SLE were studied. Three new public idiotopes, which were common to monoclonal antibodies from all three patients, were defined by five polyclonal rabbit antiidiotypes, two monoclonal mouse antiidiotopes, and a monoclonal mouse antibody against a synthetic peptide that contains residues of the heavy chain CDR-1 of a monoclonal lupus anti-DNA antibody. The antibody against the synthetic idiotype was found to react with native immunoglobulins in solution. One idiotope was found to be consistently immunogenic in all animals tested. Since the three patients are of different ethnic origins, these shared idiotypes are probably encoded by germline V genes. These genes may be recurrently expressed in states of polyclonal B-cell activation, regardless of etiology. The results suggest that some autoantibodies arise by expansion of a pool of precursors in the normal antibody repertoire.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492514      PMCID: PMC424130          DOI: 10.1172/JCI112849

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Similar idiotypic specificities in immunoglobulin fractions with different antibody functions or even without detectable antibody function.

Authors:  J Oudin; P A Cazenave
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

2.  Synthetic idiotypes: the third hypervariable region of murine anti-dextran antibodies.

Authors:  S McMillan; M V Seiden; R A Houghten; B Clevinger; J M Davie; R A Lerner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

3.  Use of glutaraldehyde as a coupling agent for proteins and peptides.

Authors:  M Reichlin
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Normal mice express idiotypes related to autoantibody idiotypes of lupus mice.

Authors:  S K Datta; B D Stollar; R S Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

5.  Experimental approaches tohomogenous antibody populations. iIndividual antigenic specificity, cross specificity and diversity of human antibodies.

Authors:  H G Kunkel
Journal:  Fed Proc       Date:  1970 Jan-Feb

6.  Detection of cross reactive anti-DNA antibody idiotypes on tissue-bound immunoglobulins from skin biopsies of lupus patients.

Authors:  D Isenberg; C Dudeney; F Wojnaruska; B S Bhogal; J Rauch; A Schattner; Y Naparstek; D Duggan
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Idiotypes of monoclonal anti-DNA antibodies produced in autoimmune B/W mice are expressed in normal mice.

Authors:  L Jacob; F Tron; M A Lety; J F Bach
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

8.  Specificity analysis of human anti-DNA antibodies.

Authors:  S Hoch; J Schwaber
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

9.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Idiotypic cross-reactions of monoclonal human lupus autoantibodies.

Authors:  Y Shoenfeld; D A Isenberg; J Rauch; M P Madaio; B D Stollar; R S Schwartz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  16 in total

Review 1.  The biochemistry and genetics of DNA and anti-DNA antibodies.

Authors:  B D Stollar
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 2.  Autoantibodies and antibacterial antibodies: from both sides now.

Authors:  R A Watts; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

3.  Chimaeric monoclonal antibodies encoded by the human VH26 gene from naïve transgenic mice display a wide range of antigen-binding specificities.

Authors:  I J Harmer; R A Mageed; A Kaminski; P Charles; M Brüggemann; C G Mackworth-Young
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

4.  Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy.

Authors:  G Bothamley; J S Beck; W Britton; A Elsaghier; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

5.  An idiotope-specific autoantibody in SLE.

Authors:  C G Mackworth-Young; R S Schwartz
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

Review 6.  Anti-DNA antibodies. Their idiotypes and SLE.

Authors:  D Buskila; Y Shoenfeld
Journal:  Clin Rev Allergy       Date:  1994

7.  A highly conserved conformational idiotope on human IgM rheumatoid factor paraproteins of the Wa cross-reactive idiotype family defined by a monoclonal antibody.

Authors:  R A Mageed; D M Goodall; R Jefferis
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

8.  The H3 anti-phospholipid idiotype is found in patients with systemic lupus erythematosus (SLE) but not in patients with syphilis.

Authors:  A Hohmann; R Comacchio; V Boswarva; M Sutjita; J Bradley
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

9.  Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease.

Authors:  A Kratz; M W Harding; J Craft; C G Mackworth-Young; R E Handschumacher
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

10.  Human monoclonal antibodies to phenolic glycolipid-I derived from patients with leprosy, and production of specific anti-idiotypes.

Authors:  M Locniskar; A Zumla; D W Mudd; D A Isenberg; W Williams; K P McAdam
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.